Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
Completed · Phase 2
Conditions studied: Bipolar I Disorder, Bipolar II Disorder, Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders, Psychomotor Agitation
In brief
This open-label study will utilize treatment with BXCL501 in order to assess the suitability of patient-and lay informant-assessed outcome measures for evaluation of severity of psychomotor agitation episodes in patients with Bipolar Disorders, Schizophrenia, Schizoaffective, and Schizophreniform disorders and correlate them with clinician-assessed ratings.
Key facts
- Study ID
- NCT07116694
- Run by
- BioXcel Therapeutics Inc
- People needed
- 33
- Starts
- 2025-06-19
- Expected to finish
- 2025-10-07
- Last updated by the study team
- 2026-08-06
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- BioXcel Clinical Research Site 103 — Chino, California, United States
- BioXcel Clinical Research Site 105 — Oceanside, California, United States
- BioXcel Clinical Research Site 102 — Orange, California, United States
- BioXcel Clinical Research Site 101 — St Louis, Missouri, United States
- BioXcel Clinical Research Site 106 — Las Vegas, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.